SWAVShockwave Medical, Inc.

Nasdaq shockwavemedical.com


$ 329.88 $ -0.28 (-0.08 %)    

Monday, 20-May-2024 15:59:52 EDT
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ 329.85
$ 330.06
$ 329.85 x 100
$ 329.89 x 127
$ 329.85 - $ 330.20
$ 157.00 - $ 331.58
531,765
na
12.38B
$ 1.51
$ 75.62
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 johnson--johnson-to-acquire-early-stage-eczema-treatment-developer-proteologix-for-850m

Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated di...

Core News & Articles

2024 Financial GuidanceGiven the proposed acquisition of Shockwave Medical by Johnson & Johnson (NYSE:JNJ), Shockwave Medic...

 shockwave-medical-q1-eps-144-beats-098-estimate-sales-21881m-beat-20769m-estimate

ShockWave Medical (NASDAQ:SWAV) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $0....

 johnson--johnson-shows-focus-on-strengthening-its-business-upon-its-consumer-health-unit-spinoff

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estima...

 5-things-to-know-in-investing-this-week---the-shockwave-takeover-issue

The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson (NYSE: JNJ)agreeing to pay $33...

 shockwave-medical-demonstrates-consistent-results-in-real-world-study-investigators-presented-6-month-data-from-the-full-population-of-the-reducer-i-study-alongside-interim-long-term-follow-up-results-to-3-years

Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for ...

 cl-king-downgrades-shockwave-medical-to-neutral

CL King analyst Kristen Stewart downgrades Shockwave Medical (NASDAQ:SWAV) from Buy to Neutral.

 leerink-partners-downgrades-shockwave-medical-to-market-perform-lowers-price-target-to-335

Leerink Partners analyst Mike Kratky downgrades Shockwave Medical (NASDAQ:SWAV) from Outperform to Market Perform and lowers...

 johnson--johnsons-13b-shockwave-medical-deal-accelerates-medtech-strategy-analyst-says

Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a stra...

 deutsche-bank-downgrades-shockwave-medical-to-hold-raises-price-target-to-335

Deutsche Bank analyst Imron Zafar downgrades Shockwave Medical (NASDAQ:SWAV) from Buy to Hold and raises the price target fr...

 disney-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 morgan-stanley-downgrades-shockwave-medical-to-equal-weight-raises-price-target-to-335

Morgan Stanley analyst Patrick Wood downgrades Shockwave Medical (NASDAQ:SWAV) from Overweight to Equal-Weight and raises th...

 canaccord-genuity-downgrades-shockwave-medical-to-hold-raises-price-target-to-335

Canaccord Genuity analyst William Plovanic downgrades Shockwave Medical (NASDAQ:SWAV) from Buy to Hold and raises the price ...

 needham-downgrades-shockwave-medical-to-hold

Needham analyst Mike Matson downgrades Shockwave Medical (NASDAQ:SWAV) from Buy to Hold.

 johnson--johnson-makes-yet-another-multi-billion-medtech-deal-with-shockwave-medical

Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfo...

 wolfe-research-downgrades-shockwave-medical-to-peer-perform

Wolfe Research analyst Mike Polark downgrades Shockwave Medical (NASDAQ:SWAV) from Outperform to Peer Perform.

 5-things-to-know-in-investing-this-week

The Shockwave Issue

 dominos-pizza-to-rally-over-11-here-are-10-top-analyst-forecasts-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 piper-sandler-maintains-overweight-on-shockwave-medical-raises-price-target-to-360

Piper Sandler analyst Adam Maeder maintains Shockwave Medical (NASDAQ:SWAV) with a Overweight and raises the price target fr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION